Advances in the speed, scale, and affordability of nucleic acid synthesis over the last two decades have catalyzed a rapidly evolving landscape in ...

Angel Yeast (SH:600298) a global leader in yeast manufacturing, has announced that its Baiyang Biotechnology Park ("the Park" ...

Biotinylated nucleotides have emerged as a powerful tool in molecular biology, enabling researchers to explore genetic materials with unprecedented precision and sensitivity. These modified ...

NIPPON SHOKUBAI CO., LTD. headquartered in Osaka, Japan, has announced a plan to expand its GMP (*1)-compliant manufacturing capacity for nucleic acid drug "active pharmaceutical ingredients" (APIs) ...

The Oligonucleotide Synthesis Market is poised for robust growth, fueled by advancements in personalized medicine, molecular diagnostics, and genomics research. However, high production costs ...

BEIJING, June 4, 2025 /PRNewswire/ -- Tsingke Biotech recently participated in TIDES USA 2025, the leading international event for oligonucleotide and peptide therapeutics, held in San Diego from ...

Codexis showcased its proprietary ECO Synthesis platform at the TIDES USA annual meeting, demonstrating significant improvements in siRNA manufacturing processes, including reduced purification ...

Oligos are playing a crucial role in driving the progress of modern drug development. Listen to nucleic acid synthesis expert Lina Borozdina deliver a complete class on oligo synthesis starting from ...

Nucleic acid synthesis screening can be most effective when preventing a baseline of clearly illegitimate customers from receiving potentially dangerous DNA. That being said, provider-conducted ...

This business combination will also allow us to strengthen our contribution to the GMP manufacturing of key enzymes needed for nucleic acid vaccine and therapeutic applications.” The acquisition is ...

Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine ...